Cargando…
PRDM14 mediates chemosensitivity and glycolysis in drug-resistant A549/cisplatin cells and their progenitor A549 human lung adenocarcinoma cells
Recent studies have reported that aberrant PR domain zinc finger protein 14 (PRDM14) expression is associated with the therapeutic sensitivity of cancer cells to drugs. However, its role in lung adenocarcinoma (LUAD) remains unclear. The present study aimed to determine the functions of knockdown or...
Autores principales: | He, Saifei, Ma, Xiaokun, Zheng, Ni, Wang, Guoyu, Wang, Menghan, Xia, Wei, Yu, Donghai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7789100/ https://www.ncbi.nlm.nih.gov/pubmed/33355367 http://dx.doi.org/10.3892/mmr.2020.11788 |
Ejemplares similares
-
Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinoma
por: Shi, Degang, et al.
Publicado: (2009) -
The effect of tetrandrine combined with cisplatin on proliferation and apoptosis of A549/DDP cells and A549 cells
por: Ye, Ling-Yun, et al.
Publicado: (2017) -
Downregulation of HIF-2α Reverse the Chemotherapy Resistance of Lung Adenocarcinoma A549 Cells to Cisplatin
por: Gao, Zhao-jia, et al.
Publicado: (2018) -
Kaempferide Enhances Chemosensitivity of Human Lung Adenocarcinoma A549 Cells Mediated by the Decrease in Phosphorylation of Akt and Claudin-2 Expression
por: Eguchi, Hiroaki, et al.
Publicado: (2020) -
Transcriptome Sequencing Reveals Key Pathways and Genes Associated with Cisplatin Resistance in Lung Adenocarcinoma A549 Cells
por: Fang, Yani, et al.
Publicado: (2017)